Sign in or Register   Sign in or Register
  |  

Rabbit Anti-HMGA2 Recombinant Antibody (D1A7) (CBMAB-H2464-FY)

This product is rabbit antibody that recognizes HMGA2. The antibody D1A7 can be used for immunoassay techniques such as: WB, IHC-P, IF.
See all HMGA2 antibodies

Summary

Host Animal
Rabbit
Specificity
Human, Mouse, Rat, Monkey
Clone
D1A7
Antibody Isotype
IgG
Application
WB, IHC-P, IF

Basic Information

Specificity
Human, Mouse, Rat, Monkey
Antibody Isotype
IgG
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
High Mobility Group AT-Hook 2
Introduction
This gene encodes a protein that belongs to the non-histone chromosomal high mobility group (HMG) protein family. HMG proteins function as architectural factors and are essential components of the enhancesome. This protein contains structural DNA-binding domains and may act as a transcriptional regulating factor. Identification of the deletion, amplification, and rearrangement of this gene that are associated with myxoid liposarcoma suggests a role in adipogenesis and mesenchymal differentiation. A gene knock out study of the mouse counterpart demonstrated that this gene is involved in diet-induced obesity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Entrez Gene ID
Human8091
Mouse15364
Rat84017
Monkey717721
UniProt ID
HumanP52926
MouseP52927
RatO88791
MonkeyF7GUA4
Alternative Names
High Mobility Group AT-Hook 2; High-Mobility Group (Nonhistone Chromosomal) Protein Isoform I-C; HMGIC; High Mobility Group AT-Hook Protein 2; High Mobility Group Protein HMGI-C; HMGA2/KRT121P Fusion
Function
Functions as a transcriptional regulator. Functions in cell cycle regulation through CCNA2. Plays an important role in chromosome condensation during the meiotic G2/M transition of spermatocytes. Plays a role in postnatal myogenesis, is involved in satellite cell activation (By similarity).

Positively regulates IGF2 expression through PLAG1 and in a PLAG1-independent manner (PubMed:28796236).
Biological Process
Base-excision repair Source: UniProtKB
Cell division Source: UniProtKB-KW
Chondrocyte differentiation Source: UniProtKB
Chondrocyte proliferation Source: UniProtKB
Chromatin organization Source: UniProtKB
Chromosome breakage Source: UniProtKB
Chromosome condensation Source: UniProtKB-KW
Endodermal cell differentiation Source: UniProtKB
Epithelial to mesenchymal transition Source: UniProtKB
Fat cell differentiation Source: UniProtKB
Heterochromatin assembly Source: UniProtKB
Histone H2A-S139 phosphorylation Source: UniProtKB
Mesenchymal cell differentiation Source: UniProtKB
Mesodermal cell differentiation Source: UniProtKB
Mesodermal-endodermal cell signaling Source: UniProtKB
Mitotic G2 DNA damage checkpoint signaling Source: UniProtKB
Negative regulation by host of viral transcription Source: UniProtKB
Negative regulation of apoptotic process Source: UniProtKB
Negative regulation of cellular senescence Source: BHF-UCL
Negative regulation of DNA binding Source: UniProtKB
Negative regulation of double-strand break repair via nonhomologous end joining Source: UniProtKB
Negative regulation of single stranded viral RNA replication via double stranded DNA intermediate Source: UniProtKB
Negative regulation of transcription, DNA-templated Source: UniProtKB
Negative regulation of transcription by RNA polymerase II Source: UniProtKB
Oncogene-induced cell senescence Source: UniProtKB
Positive regulation of angiogenesis Source: BHF-UCL
Positive regulation of apoptotic process Source: UniProtKB
Positive regulation of cell proliferation in bone marrow Source: BHF-UCL
Positive regulation of cellular response to X-ray Source: UniProtKB
Positive regulation of gene expression Source: UniProtKB
Positive regulation of protein serine/threonine kinase activity Source: UniProtKB
Positive regulation of response to DNA damage stimulus Source: UniProtKB
Positive regulation of stem cell proliferation Source: UniProtKB
Positive regulation of transcription, DNA-templated Source: UniProtKB
Positive regulation of transcription by RNA polymerase II Source: UniProtKB
Regulation of cell cycle process Source: UniProtKB
Regulation of growth Source: UniProtKB-KW
Regulation of stem cell population maintenance Source: UniProtKB
Regulation of transcription, DNA-templated Source: UniProtKB
Response to virus Source: UniProtKB
Stem cell differentiation Source: UniProtKB
Cellular Location
Nucleus
Involvement in disease
Silver-Russell syndrome 5 (SRS5):
A form of Silver-Russell syndrome, a clinically heterogeneous condition characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations. The phenotypic expression changes during childhood and adolescence, with the facial features and asymmetry usually becoming more subtle with age. SRS5 inheritance is autosomal dominant.
A chromosomal aberration involving HMGA2 is associated with a subclass of benign mesenchymal tumors known as lipomas. Translocation t(3;12)(q27-q28;q13-q15) with LPP is shown in lipomas. HMGA2 is also fused with a number of other genes in lipomas.
A chromosomal aberration involving HMGA2 is associated with pulmonary chondroid hamartomas. Translocation t(3;12)(q27-q28;q14-q15) with LPP is detected in pulmonary chondroid hamartomas.
A chromosomal aberration involving HMGA2 is associated with parosteal lipomas. Translocation t(3;12)(q28;q14) with LPP is also shown in one parosteal lipoma.
A chromosomal aberration involving HMGA2 is found in uterine leiomyoma. Translocation t(12;14)(q15;q23-24) with RAD51B. Chromosomal rearrangements involving HMGA2 do not seem to be the principle pathobiological mechanism in uterine leiomyoma.
PTM
Regulated by cell cycle-dependent phosphorylation which alters its DNA binding affinity. Phosphorylated by NEK2 (By similarity).

Hashemi, M., Rashidi, M., Hushmandi, K., Ten Hagen, T. L., Salimimoghadam, S., Taheriazam, A., ... & Falahati, M. (2023). HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response. Pharmacological Research, 106732.

Mansoori, B., Mohammadi, A., Ditzel, H. J., Duijf, P. H., Khaze, V., Gjerstorff, M. F., & Baradaran, B. (2021). HMGA2 as a critical regulator in cancer development. Genes, 12(2), 269.

Wang, X., Wang, J., & Wu, J. (2021). Emerging roles for HMGA2 in colorectal cancer. Translational Oncology, 14(1), 100894.

Rong, D., Wu, F., Lu, C., Sun, G., Shi, X., Chen, X., ... & Wang, X. (2021). m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Molecular Therapy-Nucleic Acids, 26, 637-648.

Li, Y., Qiang, W., Griffin, B. B., Gao, T., Chakravarti, D., Bulun, S., ... & Wei, J. J. (2020). HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma. Fertility and sterility, 114(5), 1085-1096.

Su, L., Bryan, N., Battista, S., Freitas, J., Garabedian, A., D’Alessio, F., ... & Leng, F. (2020). Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays. Scientific Reports, 10(1), 18850.

Mansoori, B., Duijf, P. H., Mohammadi, A., Najafi, S., Roshani, E., Shanehbandi, D., ... & Baradaran, B. (2020). Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness. Expert Opinion on Therapeutic Targets, 24(3), 255-265.

Zhang, S., Mo, Q., & Wang, X. (2019). Oncological role of HMGA2. International journal of oncology, 55(4), 775-788.

Mansoori, B., Mohammadi, A., Asadzadeh, Z., Shirjang, S., Minouei, M., Abedi Gaballu, F., ... & Baradaran, B. (2019). HMGA2 and Bach‐1 cooperate to promote breast cancer cell malignancy. Journal of Cellular Physiology, 234(10), 17714-17726.

Chiou, S. H., Dorsch, M., Kusch, E., Naranjo, S., Kozak, M. M., Koong, A. C., ... & Grüner, B. M. (2018). Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Scientific reports, 8(1), 14008.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Rabbit Anti-HMGA2 Recombinant Antibody (D1A7)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare